Showing results (371-380 of 1,483) with videos related to
Sort By:
Pageof 149
Molecular and Cellular Biology|October 1, 1993
NF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like moleculeR I Scheinman, A A Beg, A S BaldwinJournal of Biochemistry|June 1, 1996
A new inhibitor of mitochondrial fatty acid oxidationT Hashimoto, Y Shindo, M Souri, et al.Science (New York, N.Y.)|November 1, 1996
TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaBC Y Wang, M W Mayo, A S BaldwinBiochimica Et Biophysica Acta|October 13, 1993
Nucleotide sequence encoding a novel member of the hydratase/dehydrogenase familyT Mantamadiotis, P Sobieszczuk, J Weinstock, et al.BMC Genomics|April 23, 2009
The cytochrome P450 (CYP) gene superfamily in Daphnia pulexWilliam S Baldwin, Peter B Marko, David R NelsonBiofactors (Oxford, England)|March 26, 2009
Gastrin-releasing peptide: different forms, different functionsJoseph Ischia, Oneel Patel, Arthur Shulkes, et al.Human Psychopharmacology|September 22, 2016
Systematic review of blood transcriptome profiling in neuropsychiatric disorders: guidelines for biomarker discoveryMichael S Breen, Dan J Stein, David S BaldwinThe Journal of Emergency Medicine|July 1, 1993
Technical considerations in the selection of a personal emergency response systemA S Baldwin, S A Syverud, R F EdlichPlos One|March 3, 2010
IKKalpha and IKKbeta each function to regulate NF-kappaB activation in the TNF-induced/canonical pathwayMazhar Adli, Evan Merkhofer, Patricia Cogswell, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 14, 2012
Psychiatry should not become hostage to placebo: an alternative interpretation of antidepressant-placebo differences in the treatment response in depressionZoltan Rihmer, Peter Dome, David S Baldwin, et al.Pageof 149